India's Richest People 2026 edition · 1 director · Source: Hurun India
- #389 Nityananda Reddy & family ₹9,600 Cr
Revenue · FY 2025
₹6,811.62 Cr
▲ 20% YoY
Net profit · FY 2025
₹251.22 Cr
Net margin 3.7%
EBITDA · FY 2025
₹603.67 Cr
EBITDA margin 8.9%
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹99 Cr
Issued & subscribed
Open charges
₹1,500 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
4,732
Provident fund records
About Apitoria Pharma Private Limited
Data last updated:
Apitoria Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 20 December 2017 and has been in existence for over 9 years.
Its director Nityananda Reddy and family are #389 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24298TG2017PTC121342. Its GSTIN is 36AAQCA3500J1ZP (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹99 Cr. It was formerly known as Auro Pharma India Private Limited. It is led by directors including Santanu Mukherjee and Nityananda Reddy Kambam.
Its last annual general meeting (AGM) was held on 17 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹6,811.62 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹251.22 Cr (net margin 3.7%) and EBITDA of ₹603.67 Cr (EBITDA margin 8.9%).
The company has about 4,732 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1,500 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aurobindo.com.
Company details
CIN U24298TG2017PTC121342
Registration Number 121342
Incorporation Date 20 December 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 17 August 2026
Date of Balance Sheet 31 March 2026
Parent Company Aurobindo Pharma Ltd
Compliance Status Active Compliant
Recognitions & Rankings of Apitoria Pharma
Contact details
Apitoria Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is aurobindo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Apitoria Pharma Private Limited, buy the company report.
Comprehensive company report
Apitoria Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Apitoria Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Apitoria Pharma Private Limited, buy the company report.
Financials of Apitoria Pharma Private Limited
FY 2026 filings availableApitoria Pharma Private Limited reported revenue of ₹6,811.62 Cr (up 20% YoY) for FY 2025.
Revenue · FY 2025
₹6,811.62 Cr ▲ 20%
Net profit · FY 2025
₹251.22 Cr margin 3.7%
EBITDA · FY 2025
₹603.67 Cr margin 8.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
EBITDA CAGR growth
1 year
▲ 20%
Revenue rose 20% in the latest year. EBITDA rose 20% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹6,811.62 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹603.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹251.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apitoria Pharma Private Limited, buy the company report.
Board of directors and KMP of Apitoria Pharma Private Limited
Apitoria Pharma Private Limited currently reports 5 directors and 1 key managerial person. 4 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santanu Mukherjee Also directs: Aurobindo Pharma Ltd, Suven Life Sciences Limited, Sumedha Fiscal Services Ltd and 4 more | Director | 31 Jul 2025 | 1 Years 2 Months | Current |
| Nityananda Reddy Kambam Also directs: Aurobindo Pharma Ltd, Aurobindo Antibiotics Private Limited, Apl Healthcare Limited and 5 more | Director | 09 Feb 2023 | 3 Years 8 Months | Current |
| Mylandlahalli Rammohan Ashwini Also directs: Apl Healthcare Limited, Auroactive Pharma Private Limited, Eugia Sez Private Limited and 3 more | Director | 29 Mar 2024 | 2 Years 6 Months | Current |
| Satakarni Makkapati Also directs: Aurobindo Pharma Ltd, Engenra Biologics Private Limited, Theranym Biologics Private Limited and 2 more | Director | 23 May 2023 | 3 Years 5 Months | Current |
| Santhanam Subramanian Also directs: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Engenra Biologics Private Limited and 5 more | Director | 09 Feb 2023 | 3 Years 8 Months | Current |
| Sanjay Chaturvedi | Ceo | 04 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Apitoria Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ipca Laboratories Limited | ₹9,032.39 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Deccan Fine Chemicals (India) Private Limited | ₹8,738.51 Cr (FY 2024) | -1.0% | Hyderabad, Telangana, India | |||
| Emcure Pharmaceuticals Limited | ₹7,963.26 Cr (FY 2025) | 19.0% | Pune, Maharashtra, India | |||
| Mylan Laboratories Limited | ₹7,503.56 Cr (FY 2025) | -23.0% | Hyderabad, Telangana, India | |||
| Apitoria Pharma Private Limitedthis company | ₹6,811.62 Cr (FY 2025) | ₹251.22 Cr | 3.7% | 20.0% | 4,732 | Hyderabad, Telangana, India |
| MSN Laboratories Private Limited | ₹6,761.18 Cr (FY 2024) | 27.0% | Hyderabad, Telangana, India | |||
| Alembic Pharmaceuticals Limited | ₹6,714.63 Cr (FY 2025) | 7.0% | Vadodara, Gujarat, India | |||
| Gland Pharma Ltd | ₹5,830.11 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Laurus Labs Limited | ₹5,613.89 Cr (FY 2025) | 11.0% | Anakapalle, Andhra Pradesh, India | |||
| Usv Private Limited | ₹5,202.13 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Apitoria Pharma Private Limited, buy the company report.
Auditor
Apitoria Pharma Private Limited is audited by Deloitte Haskins & Sells for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2025 | 008072S |
Shareholding
The shareholding of Apitoria Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apitoria Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1,500 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Oct 2023 | 100812350 | State Bank of India | ₹1,500 Cr | Open |
To see the full charge records of Apitoria Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Apitoria Pharma Private Limited has 2 court cases on record: 1 filed by Apitoria Pharma, 1 filed against it. All cases are pending.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Limited Apepdcl and 1 other | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed against the company by an individual | Pending |
To see the full case history of Apitoria Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Apitoria Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 221 overdue payments to 67 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 67)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Shreeyansh Labs Private Limited | |||
| Baliga Lighting Equipments Private Limited | |||
| an individual supplier | |||
| Sri Balaji Gases & Chemicals |
To see the full MSME payment records of Apitoria Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Apitoria Pharma Private Limited has a workforce of 4,732 employees on its EPFO records as of Nov 04, 2025, across 1 active EPFO establishment.
Employee count
4,732
Active EPFO establishments
1
Employee growth
-0.34%
GST
Apitoria Pharma has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAQCA3500J1ZP | Telangana | Active | 06 Mar 2023 |
| 36AAQCA3500J2ZO | Telangana | Active | 11 Mar 2025 |
| 37AAQCA3500J1ZN | Andhra Pradesh | Active | 06 Mar 2023 |
To see the full GST registrations and return filing status of Apitoria Pharma Private Limited, buy the company report.
Recent activity
Apitoria Pharma Private Limited has 10 board changes on record since 2019: 6 appointments and 4 cessations. The latest: Santanu Mukherjee was appointed as Director on 31 Jul 2025.
AGM
Apitoria Pharma Private Limited last Annual general meeting of members was held on 17 Aug 2026 as per latest MCA records.
Filing
Apitoria Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
Appointed
Santanu Mukherjee was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 1,500.00 Cr registered on 30 Oct 2023 with Charge ID 100812350 was modified on 17 Apr 2025.
Appointed
Mylandlahalli Rammohan Ashwini was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 1,500.00 Cr with Charge ID 100812350 was registered on 30 Oct 2023.
Ceased
Venkat Nageswar Chalasani ceased to be Additional Director.
Appointed
Satakarni Makkapati was appointed as Director.
Appointed
Sanjay Chaturvedi was appointed as CEO.
Appointed
Nityananda Reddy Kambam was appointed as Director.
Appointed
Santhanam Subramanian was appointed as Director.
Ceased
Sarath Chandra Reddy Penaka ceased to be Director.
3 earlier events are in the company report.
News
Frequently asked questions
Apitoria Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 20 December 2017 (9+ years old) and is registered under CIN U24298TG2017PTC121342.
Apitoria Pharma has 6 current directors and KMP:
- Santanu Mukherjee - Director
- Nityananda Reddy Kambam - Director
- Mylandlahalli Rammohan Ashwini - Director
- Satakarni Makkapati - Director
- Santhanam Subramanian - Director
- Sanjay Chaturvedi - Ceo
The latest financial statements of Apitoria Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 17 August 2026. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Apitoria Pharma is 36AAQCA3500J1ZP, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AAQCA3500J2ZO (Telangana), 37AAQCA3500J1ZN (Andhra Pradesh).
The CIN (Corporate Identification Number) of Apitoria Pharma is U24298TG2017PTC121342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apitoria Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending.
Apitoria Pharma was incorporated on 20 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Apitoria Pharma by revenue are Ipca Laboratories Limited, Deccan Fine Chemicals (India) Private Limited, Emcure Pharmaceuticals Limited, Mylan Laboratories Limited, MSN Laboratories Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Santanu Mukherjee was appointed as Director on 31 Jul 2025. Mylandlahalli Rammohan Ashwini was appointed as Director on 29 Mar 2024. Venkat Nageswar Chalasani ceased to be Additional Director on 20 Aug 2023. Apitoria Pharma has 10 board changes on record in total.
Apitoria Pharma has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 221 overdue payments to 67 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Apitoria Pharma can be reached through the website aurobindo.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Apitoria Pharma is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.